Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study

被引:4
作者
Barros, Vitor [1 ]
Pereira, Marta [1 ,2 ]
Araujo, Carla [1 ,2 ,3 ]
Braga, Pedro [4 ]
Azevedo, Ana [1 ,2 ]
机构
[1] Univ Porto ISPUP, Inst Publ Hlth, Oporto, Portugal
[2] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal
[3] Ctr Hosp Tras Os Montes & Alto Douro, Dept Cardiol, Vila Real, Portugal
[4] Ctr Hosp Vila Nova de Gaia Espinho, Dept Cardiol, Vila Nova De Gaia, Portugal
关键词
Acute coronary syndrome; Coronary angioplasty; Myocardial infarction; Stent; Unstable angina; ELEVATION MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; PRIMARY ANGIOPLASTY; ANTITHROMBOTIC THERAPY; THROMBOLYTIC THERAPY; EUROPEAN-SOCIETY; TASK-FORCE; OUTCOMES; IMPLANTATION; GUIDELINES;
D O I
10.1016/j.repc.2015.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and Objectives: The interventional cardiologist chooses a specific stent type based on the risk-benefit profile for each case. In general, drug-eluting stents should be considered in all clinical conditions, except if there are concerns or contraindications for prolonged dual antiplatelet therapy. The aim of this work was to describe the use of bare-metal vs. drug-eluting stents in patients undergoing percutaneous coronary intervention (PCI) after an acute coronary syndrome in Portuguese hospitals, according to patients' demographic and clinical characteristics and institutional characteristics. Methods: Within the EURopean Hospital Benchmarking Processes (EURHOBOP) study, we retrospectively assessed 3009 consecutive patients in 10 Portuguese hospitals in 2009. Only patients with stents implanted during PCI (n=1194) were analyzed. Results: A total of 425 patients (36%) received a bare-metal stent and 769 patients (64%) received a drug-eluting stent. A history of previous PCI, current non-ST-elevation myocardial infarction, anterior descending artery as the infarct-related artery and being initially admitted to a hospital with a catheterization laboratory were associated with drug-eluting stent implantation. Age under 45 or over 80, anemia and previous anticoagulation and/or atrial fibrillation were associated with bare-metal stent use. Conclusions: Approximately two-thirds of patients received drug-eluting stents, which were less frequently implanted in patients with ST-elevation myocardial infarction, aged over 80 years, female, with a previous history of stroke, anticoagulation and/or atrial fibrillation and anemia. Patients who had previously undergone PCI and those with the anterior descending artery as the infarct-related artery were more likely to receive a drug-eluting stent. (C) 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 50 条
[41]   Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in Sweden. [J].
James, Stefan K. ;
Stenestrand, Ulf ;
Lindback, Johan ;
Carlsson, Jorg ;
Schersten, Fredrik ;
Nilsson, Tage ;
Wallentin, Lars ;
Lagerqvist, Bo .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (19) :1933-1945
[43]   Identification of independent risk factors for restenosis following bare-metal stent implantation: Role of bare-metal stents in the era of drug-eluting stents [J].
Park, Chang-Bum ;
Park, Hoon-Ki .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (03) :840-846
[44]   Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction: Drug-Eluting Stents or Bare Metal Stents? [J].
Iyengar, Srinivas ;
Rabbani, LeRoy E. .
AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (05) :516-522
[45]   Outcomes of drug-eluting stents compared to bare-metal stents in ST-segment elevation acute myocardial infarction [J].
Brito, Joao ;
Almeida, Manuel ;
Teles, Rui Campante ;
Sousa, Pedro ;
Abecasis, Joao ;
Cale, Rita ;
Goncalves, Pedro ;
Raposo, Luis ;
Mendes, Miguel .
REVISTA PORTUGUESA DE CARDIOLOGIA, 2011, 30 (11) :813-819
[46]   Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention [J].
Yeh, Robert W. ;
Normand, Sharon-Lise T. ;
Wolf, Robert E. ;
Jones, Philip G. ;
Ho, Kalon K. L. ;
Cohen, David J. ;
Cutlip, Donald E. ;
Mauri, Laura ;
Kugelmass, Aaron D. ;
Amin, Amit P. ;
Spertus, John A. .
CIRCULATION, 2011, 124 (14) :1557-+
[47]   Pathology of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Lesions [J].
Yazdani, Saami K. ;
Farb, Andrew ;
Nakano, Masataka ;
Vorpahl, Marc ;
Ladich, Elena ;
Finn, Aloke V. ;
Kolodgie, Frank D. ;
Virmani, Renu .
JACC-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (06) :666-674
[48]   Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis [J].
Almalla, Mohammad ;
Pross, Verena ;
Marx, Nikolaus ;
Hoffmann, Rainer .
CORONARY ARTERY DISEASE, 2012, 23 (07) :492-496
[49]   Drug-Eluting Stents Are Not Indicated for Patients With Acute Coronary Syndrome - Should Drug-Eluting Stents Be Indicated for Patients With Acute Coronary Syndrome? (Con) - [J].
Inoue, Katsumi .
CIRCULATION JOURNAL, 2010, 74 (10) :2232-2238
[50]   Safety and Effectiveness of Drug-Eluting Versus Bare-Metal Stents in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions [J].
Aggarwal, Vikas ;
Stanislawski, Maggie A. ;
Maddox, Thomas M. ;
Nallamothu, Brahmajee K. ;
Grunwald, Gary ;
Adams, Jill C. ;
Ho, P. Michael ;
Rao, Sunil V. ;
Casserly, Ivan P. ;
Rumsfeld, John S. ;
Brilakis, Emmanouil S. ;
Tsai, Thomas T. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (17) :1825-1836